Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial

NCT05157295 is registered in ClinicalTrials.gov with Augusta University as lead sponsor.

NCT NCT05157295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
Lead sponsor
Augusta University
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2022
Completion date
September 30, 2022
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, overactive bladder syndrome